Pharma industry calls for stronger IP protection in free trade agreements

Amid global criticism for holding on to vaccine patents during the pandemic, a new study commissioned by the European pharmaceuticals industry claims that integrating stronger intellectual property protection into free trade agreements would benefit the EU economy.

According to this study, the pharmaceutical industry is the most IP-intensive industry in Europe, followed by the ICT and electronics sector. Trademarks, copyrights, patents, and geographical indications were considered as the relevant IP categories in the study.


Read more.